Otitis media with effusion
Also known as: Glue ear, Middle-ear effusion, Serous otitis media, Secretory otitis media, Non-suppurative otitis media
Otitis media with effusion (OME) is characterised by fluid accumulation behind an intact tympanic membrane without acute inflammatory signs. It commonly causes fluctuating conductive hearing loss in children and may affect communication and learning. Assessment centres on otoscopy, tympanometry, and age-appropriate hearing assessment; persistent or unilateral adult effusion requires medical investigation. While Chinese medicine patterns may structure adjunctive symptom support, the supplied records provide no evidence that acupuncture or herbal formulas clear effusion or improve hearing. These records concern CT classification, observational childhood associations, an abstract-free surgical letter, and post-radiotherapy hearing impairment; they do not establish treatment recommendations. Medical surveillance and indicated ENT care remain essential.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Optimise communication by securing the patient's attention prior to vocalisation, maintaining direct visual contact, and minimising ambient noise; facilitate preferential classroom seating and educational support where indicated.
- •Maintain a brief record of hearing difficulties, ear symptoms, sleep, and communication changes to share during medical reviews.
- •Ensure a strictly smoke-free domestic and vehicular environment; maintain adherence to the national immunisation schedule and routine preventive healthcare protocols.
- •Prioritise adequate rest and balanced nutrition; avoid restrictive 'dampness' diets. Observational data regarding infant feeding and delivery methods do not justify clinical modification of medically advised obstetric plans or parental culpability.
Cautions & Contraindications
- •Do not let acupuncture or herbs delay hearing testing, ENT investigation or indicated surgery. The supplied CT study is diagnostic research, not evidence for routine CT or for adjunctive treatment; the adenoidectomy letter has no abstract from which to derive recommendations.[,]
- •Do not presume an adult formula is safe for a child or offer herbal treatment instead of developmental and hearing assessment. The supplied childhood study evaluates associations, not acupuncture efficacy, herbal safety or paediatric dosing.[]
- •For patients receiving cancer treatment or with irradiated tissue, coordinate with the oncology and ENT teams before needling or herbs; avoid damaged skin and assess infection and bleeding risks. The supplied review supports attention to post-radiotherapy hearing loss but does not establish acupuncture safety or benefit.[]
When to reassess or seek care again
Document baseline otoscopy or tympanometry findings when available, age-appropriate hearing results, symptom duration, laterality and communication impact. If adjunctive care is chosen, review comfort and functional listening after 2–4 weeks and stop if there is no meaningful benefit or any adverse effect. Ensure medical and audiology reassessment by approximately three months from known onset or diagnosis if effusion persists, sooner for significant hearing difficulties, developmental concerns or high-risk patients. Persistent adult unilateral effusion requires prompt ENT assessment rather than this observation interval. Symptom improvement alone does not confirm fluid resolution. These are pragmatic clinical precautions, not schedules established by the supplied abstracts.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- BMC medical imaging · 2026
- European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
- Medicine · 2025
- Molecular and clinical oncology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
